Trial Profile
A Phase I Study of Systemic Gene Therapy RB-94 in Solid Tumors With No Standard Therapy
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 02 Nov 2015
Price :
$35
*
At a glance
- Drugs SGT-94 (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 02 Nov 2015 New trial record